Kailera Therapeutics Q3 EPS $(0.74) Beats $(1.02) Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings Beats
Kailera Therapeutics (NASDAQ:KLRA) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(1.02) by 27.45 percent.
Kailera Therapeutics (NASDAQ:KLRA) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(1.02) by 27.45 percent.